{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:22:20Z","timestamp":1790634140505,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11064-013-1188-8","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T02:43:38Z","timestamp":1384137818000},"page":"37-45","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency"],"prefix":"10.1007","volume":"39","author":[{"given":"Patrizia","family":"Garbati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Adriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Salis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Damonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Millo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Balestrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"issue":"3","key":"1188_CR1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80(3):1107\u20131213","journal-title":"Physiol Rev"},{"issue":"3","key":"1188_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1113\/jphysiol.2001.013478","volume":"537","author":"PL Greenhaff","year":"2001","unstructured":"Greenhaff PL (2001) The creatine\u2013phosphocreatine system: there\u2019s more than one song in its repertoire. J Physiol 537(3):657. doi: 10.1113\/jphysiol.2001.013478","journal-title":"J Physiol"},{"issue":"1\u20133","key":"1188_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00726-001-0133-3","volume":"23","author":"M Balestrino","year":"2002","unstructured":"Balestrino M, Lensman M, Parodi M, Perasso L, Rebaudo R, Melani R, Polenov S, Cupello A (2002) Role of creatine and in neuronal protection from anoxic and ischemic damage. Amino Acids 23(1\u20133):221\u2013229. doi: 10.1007\/s00726-001-0133-3","journal-title":"Amino Acids"},{"issue":"2","key":"1188_CR4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/med.20255","volume":"33","author":"L Perasso","year":"2013","unstructured":"Perasso L, Spallarossa P, Gandolfo C, Ruggeri P, Balestrino M (2013) Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives. Med Res Rev 33(2):336\u2013363. doi: 10.1002\/med.20255","journal-title":"Med Res Rev"},{"key":"1188_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347\u2013350. doi: 10.1038\/6568","journal-title":"Nat Med"},{"issue":"4","key":"1188_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12017-008-8053-y","volume":"10","author":"PJ Adhihetty","year":"2008","unstructured":"Adhihetty PJ, Beal MF (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromol Med 10(4):275\u2013290. doi: 10.1007\/s12017-008-8053-y","journal-title":"Neuromol Med"},{"issue":"5","key":"1188_CR7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","volume":"40","author":"MF Beal","year":"2011","unstructured":"Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40(5):1305\u20131313. doi: 10.1007\/s00726-011-0851-0","journal-title":"Amino Acids"},{"key":"1188_CR8","doi-asserted-by":"crossref","unstructured":"Wang J, Xiao Y, Chen S, Zhong C, Luo M, Luo H (2012) Creatine for Parkinson\u2019s disease. Cochrane Database Syst Rev Issue 2. doi: 10.1002\/14651858.CD009646","DOI":"10.1002\/14651858.CD009646"},{"issue":"1\u20132","key":"1188_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(03)02547-2","volume":"974","author":"L Perasso","year":"2003","unstructured":"Perasso L, Cupello A, Lunardi GL, Principato C, Gandolfo C, Balestrino M (2003) Kinetics of creatine in blood and brain after intraperitoneal injection in the rat. Brain Res 974(1\u20132):37\u201342. doi: 10.1016\/S0006-8993(03)02547-2","journal-title":"Brain Res"},{"issue":"4","key":"1188_CR10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuroscience.2006.06.058","volume":"142","author":"G Lunardi","year":"2006","unstructured":"Lunardi G, Parodi A, Perasso L, Pohvozcheva AV, Scarrone S, Adriano E, Florio T, Gandolfo C, Cupello A, Burov SV, Balestrino M (2006) The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience 142(4):991\u2013997. doi: 10.1016\/j.neuroscience.2006.06.058","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"1188_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011908606819","volume":"224","author":"RJ Snow","year":"2001","unstructured":"Snow RJ, Murphy RM (2001) Creatine and the creatine transporter: a review. Mol Cell Biochem 224(1\u20132):169\u2013181. doi: 10.1023\/A:1011908606819","journal-title":"Mol Cell Biochem"},{"issue":"1\u20132","key":"1188_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1022487218904","volume":"244","author":"TJ deGrauw","year":"2003","unstructured":"deGrauw TJ, Cecil KM, Byars AW, Salomons GS, Ball WS, Jakobs C (2003) The clinical syndrome of creatine transporter deficiency. Mol Cell Biochem 244(1\u20132):45\u201348. doi: 10.1023\/A:1022487218904","journal-title":"Mol Cell Biochem"},{"issue":"2\u20133","key":"1188_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1024405821638","volume":"26","author":"GS Salomons","year":"2003","unstructured":"Salomons GS, van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, DeGrauw TJ, Jakobs C (2003) X-linked creatine transporter defect: an overview. J Inherit Metab Dis 26(2\u20133):309\u2013318","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1188_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/422102","volume":"75","author":"EH Rosenberg","year":"2004","unstructured":"Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, Moraine C, Ropers HH, Fryns JP, deGrauw TJ, Jakobs C, Salomons GS (2004) High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 75(1):97\u2013105. doi: 10.1086\/422102","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1188_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004703-200508000-00003","volume":"26","author":"A Newmeyer","year":"2005","unstructured":"Newmeyer A, Cecil KM, Schapiro M, Clark JF, Degrauw TJ (2005) Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J Dev Behav Pediatr 26(4):276\u2013282. doi: 10.1097\/00004703-200508000-00003","journal-title":"J Dev Behav Pediatr"},{"issue":"6","key":"1188_CR16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00439-006-0162-9","volume":"119","author":"AJ Clark","year":"2006","unstructured":"Clark AJ, Rosenberg EH, Almeida LS, Wood TC, Jakobs C, Stevenson RE, Schwartz CE, Salomons GS (2006) X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119(6):604\u2013610. doi: 10.1007\/s00439-006-0162-9","journal-title":"Hum Genet"},{"issue":"9","key":"1188_CR17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/01.wnl.0000239153.39710.81","volume":"67","author":"L Lion-Fran\u00e7ois","year":"2006","unstructured":"Lion-Fran\u00e7ois L, Cheillan D, Pitelet G, Acquaviva-Bourdain C, Bussy G, Cotton F, Guibaud L, G\u00e9rard D, Rivier C, Vianey-Saban C, Jakobs C, Salomons GS, des Portes V (2006) High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67(9):1713\u20131714. doi: 10.1212\/01.wnl.0000239153.39710.81","journal-title":"Neurology"},{"issue":"16\u201317","key":"1188_CR18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.clinbiochem.2007.07.010","volume":"40","author":"A Arias","year":"2007","unstructured":"Arias A, Corbella M, Fons C, Sempere A, Garc\u00eda-Villoria J, Ormazabal A, Poo P, Pineda M, Vilaseca MA, Campistol J, Briones P, P\u00e0mpols T, Salomons GS, Ribes A, Artuch R (2007) Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening. Clin Biochem 40(16\u201317):1328\u20131331. doi: 10.1016\/j.clinbiochem.2007.07.010","journal-title":"Clin Biochem"},{"issue":"9","key":"1188_CR19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/psc.1379","volume":"17","author":"S Burov","year":"2011","unstructured":"Burov S, Leko M, Dorosh M, Dobrodumov A, Veselkina O (2011) Creatinyl amino acids\u2014new hybrid compounds with neuroprotective activity. J Pept Sci 17(9):620\u2013626. doi: 10.1002\/psc.1379","journal-title":"J Pept Sci"},{"key":"1188_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11064-007-9492-9","volume":"33","author":"L Perasso","year":"2008","unstructured":"Perasso L, Lunardi G, Risso F, Pohvozcheva A, Leko M, Gandolfo C, Florio T, Cupello A, Burov S, Balestrino M (2008) Protective effects of some creatine derivatives in brain tissue anoxia. Neurochem Res 33:765\u2013775. doi: 10.1007\/s11064-007-9492-9","journal-title":"Neurochem Res"},{"key":"1188_CR21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0006-8993(98)01131-7","volume":"816","author":"M Balestrino","year":"1999","unstructured":"Balestrino M, Rebaudo R, Lunardi G (1999) Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Res 816:124\u2013130. doi: 10.1016\/S0006-8993(98)01131-7","journal-title":"Brain Res"},{"key":"1188_CR22","unstructured":"Millo E, Balestrino M, Damonte G, Garbati P, Adriano E, Salis A (2012) Procedimento per sintetizzare derivati della creatina. Patent number TO2012 A001098"},{"issue":"6","key":"1188_CR23","first-page":"1","volume":"44","author":"P Garbati","year":"2013","unstructured":"Garbati P, Salis A, Adriano E, Galatini A, Damonte G, Balestrino M, Millo E (2013) A new method to synthesize creatine derivatives. Amino Acids 44(6):1\u201313. doi: 10.1007\/s00726-013-1525-x","journal-title":"Amino Acids"},{"key":"1188_CR24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuroscience.2011.09.018","volume":"199","author":"E Adriano","year":"2011","unstructured":"Adriano E, Garbati P, Damonte G, Salis A, Armirotti A, Balestrino M (2011) Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro. Neuroscience 199:386\u2013393. doi: 10.1016\/j.neuroscience.2011.09.018","journal-title":"Neuroscience"},{"key":"1188_CR25","first-page":"208","volume":"13","author":"P Andersen","year":"1971","unstructured":"Andersen P, Bliss TV, Skrede KK (1971) Unit analysis of hippocampal population spikes. Exp Brain Res 13:208\u2013221. doi: 10.1007\/BF00234086","journal-title":"Exp Brain Res"},{"key":"1188_CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-642-58552-4_9","volume-title":"Modern techniques in neuroscience research","author":"K Ballanyi","year":"1999","unstructured":"Ballanyi K (1999) In vitro preparations. In: Windhorst U, Johansson H (eds) Modern techniques in neuroscience research. Springer, Heidelberg, pp 307\u2013326"},{"key":"1188_CR27","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1471-4159.1981.tb06337.x","volume":"37","author":"TS Whittingham","year":"1981","unstructured":"Whittingham TS, Lipton P (1981) Cerebral synaptic transmission during anoxia is protected by creatine. J Neurochem 37:1618\u20131621","journal-title":"J Neurochem"},{"key":"1188_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1989.sp017638","volume":"413","author":"IS Kass","year":"1989","unstructured":"Kass IS, Lipton P (1989) Protection of hippocampal slices from young rats against anoxic transmission damage is due to better maintenance of ATP. J Physiol 413:1\u201311","journal-title":"J Physiol"},{"issue":"23","key":"1188_CR29","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/S0024-3205(99)00512-3","volume":"65","author":"JM Schedel","year":"1999","unstructured":"Schedel JM, Tanaka H, Kiyonaga A, Shindo M, Schutz Y (1999) Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations. Life Sci 65(23):2463\u20132470. doi: 10.1016\/S0024-3205(99)00512-3","journal-title":"Life Sci"},{"key":"1188_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/abbi.1998.0959","volume":"361","author":"W Dai","year":"1999","unstructured":"Dai W, Vinnakota S, Qian X, Kunze DL, Sarkar HK (1999) Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes. Arch Biochem Biophys 361:75\u201384. doi: 10.1006\/abbi.1998.0959","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1188_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohon RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76\u201385","journal-title":"Anal Biochem"},{"key":"1188_CR32","unstructured":"Bergmeyer HU (1974) In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol 1. Verlag Chemie\/Academic Press, New York\/London, pp 425\u2013426"},{"issue":"4","key":"1188_CR33","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1152\/jn.00386.2005","volume":"95","author":"W Song","year":"2006","unstructured":"Song W, Chattipakorn SC, McMahon LL (2006) Glycine-gated chloride channels depress synaptic transmission in rat hippocampus. J Neurophysiol 95(4):2366\u20132379. doi: 10.1152\/jn.00386.2005","journal-title":"J Neurophysiol"},{"key":"1188_CR34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S0033583500004340","volume":"25","author":"H Betz","year":"1992","unstructured":"Betz H (1992) Structure and function of inhibitory glycine receptors. Q Rev Biophys 25:381\u2013394","journal-title":"Q Rev Biophys"},{"issue":"2","key":"1188_CR35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00441-006-0261-x","volume":"326","author":"J Kirsch","year":"2006","unstructured":"Kirsch J (2006) Glycinergic transmission. Cell Tissue Res 326(2):535\u2013540. doi: 10.1007\/s00441-006-0261-x","journal-title":"Cell Tissue Res"},{"issue":"3","key":"1188_CR36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00221-004-2079-7","volume":"161","author":"A Barth","year":"2004","unstructured":"Barth A, Nguyen LB, Barth L, Newell DW (2004) Glycine-induced neurotoxicity in organotypic hippocampal slice cultures. Exp Brain Res 161(3):351\u2013357. doi: 10.1007\/s00221-004-2079-7","journal-title":"Exp Brain Res"},{"issue":"7","key":"1188_CR37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1011624421505","volume":"26","author":"P Saransaari","year":"2001","unstructured":"Saransaari P, Oja SS (2001) Characteristics of hippocampal glycine release in cell-damaging conditions in the adult and developing mouse. Neurochem Res 26(7):845\u2013852. doi: 10.1023\/A:1011624421505","journal-title":"Neurochem Res"},{"issue":"3","key":"1188_CR38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.jcbfm.9600351","volume":"27","author":"K Prass","year":"2007","unstructured":"Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, St\u00f6ckler-Ipsiroglu G, Wallimann T, Priller J (2007) Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cereb Blood Flow Metab 27(3):452\u2013459. doi: 10.1038\/sj.jcbfm.9600351","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-013-1188-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1188-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T10:45:39Z","timestamp":1564656339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-013-1188-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s11064-013-1188-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,12]]}}}